BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32593708)

  • 1. The genetic factors associated with Wnt signaling pathway in colorectal cancer.
    Aghabozorgi AS; Ebrahimi R; Bahiraee A; Tehrani SS; Nabizadeh F; Setayesh L; Jafarzadeh-Esfehani R; Ferns GA; Avan A; Rashidi Z
    Life Sci; 2020 Sep; 256():118006. PubMed ID: 32593708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
    Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
    Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Polymorphisms in APC, DVL2, and AXIN1 Are Associated with Susceptibility, Advanced TNM Stage or Tumor Location in Colorectal Cancer.
    Rosales-Reynoso MA; Saucedo-Sariñana AM; Contreras-Díaz KB; Márquez-González RM; Barros-Núñez P; Pineda-Razo TD; Marin-Contreras ME; Durán-Anguiano Ó; Gallegos-Arreola MP; Flores-Martínez SE; Sánchez-Corona J
    Tohoku J Exp Med; 2019 Nov; 249(3):173-183. PubMed ID: 31723073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the Wnt/β-catenin and RAS-ERK pathways involving co-stabilization of both β-catenin and RAS plays important roles in the colorectal tumorigenesis.
    Lee SK; Hwang JH; Choi KY
    Adv Biol Regul; 2018 May; 68():46-54. PubMed ID: 29449169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
    Cheng X; Xu X; Chen D; Zhao F; Wang W
    Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop.
    Li T; Jian X; He H; Lai Q; Li X; Deng D; Liu T; Zhu J; Jiao H; Ye Y; Wang S; Yang M; Zheng L; Zhou W; Ding Y
    J Exp Clin Cancer Res; 2018 Sep; 37(1):238. PubMed ID: 30253791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adenomatous polyposis coli (APC) gene mutations in the pathogenesis of colorectal cancer; current status and perspectives.
    Aghabozorgi AS; Bahreyni A; Soleimani A; Bahrami A; Khazaei M; Ferns GA; Avan A; Hassanian SM
    Biochimie; 2019 Feb; 157():64-71. PubMed ID: 30414835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability.
    Shimizu Y; Ikeda S; Fujimori M; Kodama S; Nakahara M; Okajima M; Asahara T
    Genes Chromosomes Cancer; 2002 Jan; 33(1):73-81. PubMed ID: 11746989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Aspects of Colorectal Adenomas: The Interplay among Microenvironment, Oxidative Stress, and Predisposition.
    Aceto GM; Catalano T; Curia MC
    Biomed Res Int; 2020; 2020():1726309. PubMed ID: 32258104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer.
    Zhang L; Shay JW
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28423402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review).
    Chen Y; Chen M; Deng K
    Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36579676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
    Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
    Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Wnt signaling pathway in colorectal cancer.
    Sawa M; Masuda M; Yamada T
    Expert Opin Ther Targets; 2016; 20(4):419-29. PubMed ID: 26439805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
    Prossomariti A; Piazzi G; D'Angelo L; Miccoli S; Turchetti D; Alquati C; Montagna C; Bazzoli F; Ricciardiello L
    Mol Cancer Res; 2018 Dec; 16(12):1965-1976. PubMed ID: 30072583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer.
    Kwak B; Kim DU; Kim TO; Kim HS; Kim SW
    Int J Oncol; 2018 Oct; 53(4):1800-1808. PubMed ID: 30066856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression.
    Kramer N; Schmöllerl J; Unger C; Nivarthi H; Rudisch A; Unterleuthner D; Scherzer M; Riedl A; Artaker M; Crncec I; Lenhardt D; Schwarz T; Prieler B; Han X; Hengstschläger M; Schüler J; Eferl R; Moriggl R; Sommergruber W; Dolznig H
    Oncogene; 2017 Sep; 36(39):5460-5472. PubMed ID: 28553956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and mutation pattern of β-catenin and adenomatous polyposis coli in colorectal cancer patients.
    Abdelmaksoud-Damak R; Miladi-Abdennadher I; Triki M; Khabir A; Charfi S; Ayadi L; Frikha M; Sellami-Boudawara T; Mokdad-Gargouri R
    Arch Med Res; 2015 Jan; 46(1):54-62. PubMed ID: 25660336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
    Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
    Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of WNT/β-catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations.
    Park YL; Kim HP; Cho YW; Min DW; Cheon SK; Lim YJ; Song SH; Kim SJ; Han SW; Park KJ; Kim TY
    Int J Cancer; 2019 Jan; 144(2):389-401. PubMed ID: 29978469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.